Akacia Medical (Pty) Ltd Revenue and Competitors

Johannesburg, South Africa

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Akacia Medical (Pty) Ltd's estimated annual revenue is currently $51.4M per year.(i)
  • Akacia Medical (Pty) Ltd's estimated revenue per employee is $297,000

Employee Data

  • Akacia Medical (Pty) Ltd has 173 Employees.(i)
  • Akacia Medical (Pty) Ltd grew their employee count by 21% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$10.4M48N/AN/AN/A
#2
$51.4M17321%N/AN/A
#3
$45.1M1529%N/AN/A
#4
$9.9M467%N/AN/A
#5
$0.8M60%N/AN/A
#6
$36.2M13424%N/AN/A
#7
$9.9M460%N/AN/A
#8
$5.3M288%N/AN/A
#9
$9.3M4359%N/AN/A
#10
$10.4M4830%N/AN/A
Add Company

What Is Akacia Medical (Pty) Ltd?

Akacia Medicalᅢᄁ¬ダᅡᄁ (Pty) Ltd, Trading as Akacia Medical & Healthcare Group is dedicated to providing a comprehensive range of quality medical products to the healthcare industry specialising in urology, respiratory, surgical disposables and specialized emergency equipment. We manufacture, market and distribute medical devices and consumables, as well as related surgical consumables. Our customers include hospitals, wholesalers and retail pharmacies. We also operate in niche market segments such as emergency medicine, critical care, and anaesthesia. We believe that universal access to quality health products is a right for every patient, hence our commitment to providing accessibility to healthcare solutions to the broader African continent and other countries globally through exports. Our manufacturing plants in Cape Town and Port Elizabeth adhere to world-class standards and are therefore certified with an ISO 13485 accreditation. Our current subsidiaries are: Medical, Clinisutᅢᄁ¬ダᅡᄁ & MSQ Diagnostics.

keywords:N/A

N/A

Total Funding

173

Number of Employees

$51.4M

Revenue (est)

21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$27.6M17333%N/A
#2
N/A17420%N/A
#3
$40.2M17423%N/A
#4
$43.7M17534%N/A
#5
$40.7M17621%N/A